Vanda Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ US9216591084

SecurityVNDA / Vanda Pharmaceuticals Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership93,404 shares
Latest Disclosed Value $ 440,866
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in VNDA / Vanda Pharmaceuticals Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 93,404 shares of Vanda Pharmaceuticals Inc. (US:VNDA) valued at $440,867 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 93,404 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $563,226 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Vanda Pharmaceuticals EC US9216591084 93,404 0 0.00 441 2.80 0.0099
2025-05-28 2025-03-31 NP Vanda Pharmaceuticals EC US9216591084 93,404 0 0.00 429 -4.25 0.0103
2025-02-25 2024-12-31 NP Vanda Pharmaceuticals EC US9216591084 93,404 -20,254 -17.82 447 -16.14 0.0098
2024-11-26 2024-09-30 NP Vanda Pharmaceuticals EC US9216591084 113,658 9,026 8.63 533 -9.81 0.0101
2024-08-26 2024-06-30 NP Vanda Pharmaceuticals EC US9216591084 104,632 0 0.00 591 37.44 0.0120
2024-05-28 2024-03-31 NP Vanda Pharmaceuticals EC US9216591084 104,632 0 0.00 430 -2.49 0.0090
2024-02-26 2023-12-31 NP Vanda Pharmaceuticals EC US9216591084 104,632 9,200 9.64 442 7.04 0.0094
2023-11-28 2023-09-30 NP Vanda Pharmaceuticals EC US9216591084 95,432 0 0.00 412 -34.39 0.0108
2023-08-25 2023-06-30 NP Vanda Pharmaceuticals EC US9216591084 95,432 7,851 8.96 629 5.72 0.0149
2023-05-26 2023-03-31 NP Vanda Pharmaceuticals EC US9216591084 87,581 0 0.00 595 -8.19 0.0158
2023-02-24 2022-12-31 NP Vanda Pharmaceuticals EC US9216591084 87,581 -8,175 -8.54 647 -31.61 0.0178
2022-11-25 2022-09-30 NP Vanda Pharmaceuticals EC US9216591084 95,756 11,148 13.18 946 2.60 0.0271
2022-08-25 2022-06-30 NP Vanda Pharmaceuticals EC US9216591084 84,608 0 0.00 922 -3.56 0.0255
2022-05-26 2022-03-31 NP Vanda Pharmaceuticals EC US9216591084 84,608 529 0.63 957 -27.52 0.0223
2022-02-25 2021-12-31 NP Vanda Pharmaceuticals EC US9216591084 84,079 3,329 4.12 1,319 -4.70 0.0286
2021-11-24 2021-09-30 NP Vanda Pharmaceuticals EC US9216591084 80,750 0 0.00 1,384 -20.28 0.0305
2021-08-26 2021-06-30 NP Vanda Pharmaceuticals EC US9216591084 80,750 -288 -0.36 1,737 42.65 0.0373
2021-05-27 2021-03-31 NP Vanda Pharmaceuticals EC US9216591084 81,038 -6,118 -7.02 1,217 6.29 0.0276
2021-02-25 2020-12-31 NP Vanda Pharmaceuticals EC US9216591084 87,156 0 0.00 1,145 36.15 0.0293
2020-11-25 2020-09-30 NP Vanda Pharmaceuticals EC US9216591084 87,156 0 0.00 842 -15.65 0.0270
2020-08-27 2020-06-30 NP Vanda Pharmaceuticals EC US9216591084 87,156 1,377 1.61 997 12.27 0.0326
2020-06-01 2020-03-31 NP Vanda Pharmaceuticals EC US9216591084 85,779 5,216 6.47 889 -32.83 0.0363
2020-02-27 2019-12-31 NP Vanda Pharmaceuticals EC 921659108 80,563 1,159 1.46 1,322 25.43 0.0398
2019-11-27 2019-09-30 NP Vanda Pharmaceuticals EC US9216591084 79,404 79,404 1,054 0.0349
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.